• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双重作用的β2 激动剂/毒蕈碱拮抗剂。

Dual-acting beta2 agonists/muscarinic antagonists.

机构信息

Norman Consulting, 18 Pink Lane, Burnham, Buckinghamshire, SL1 8JW, UK.

出版信息

Expert Opin Ther Pat. 2006 Sep;16(9):1327-31. doi: 10.1517/13543776.16.9.1327.

DOI:10.1517/13543776.16.9.1327
PMID:20144061
Abstract

Bifunctional aromatic derivatives that act as both beta(2) agonists and muscarinic receptor antagonists are claimed. The compounds use two separate pharmacophoric groups, coupled by a long lipohilic chain, to provide the desired biological activities and with the aim of providing a long duration of action. The compounds are claimed to be useful in the treatment of both asthma and chronic obstructive pulmonary disease and represent the first disclosure of a new concept - muscarinic antagonist-beta(2) agonists.

摘要

据称,有一种双功能芳香衍生物,它既能作为β2 激动剂,又能作为毒蕈碱受体拮抗剂。这些化合物使用两个独立的药效团,通过一条长的亲脂链连接,以提供所需的生物活性,并旨在提供长效作用。这些化合物据称可用于治疗哮喘和慢性阻塞性肺疾病,代表了一个新概念的首次披露 - 毒蕈碱受体拮抗剂-β2 激动剂。

相似文献

1
Dual-acting beta2 agonists/muscarinic antagonists.双重作用的β2 激动剂/毒蕈碱拮抗剂。
Expert Opin Ther Pat. 2006 Sep;16(9):1327-31. doi: 10.1517/13543776.16.9.1327.
2
Long-acting muscarinic M3 receptor antagonists.长效毒蕈碱 M3 受体拮抗剂。
Expert Opin Ther Pat. 2006 Sep;16(9):1315-20. doi: 10.1517/13543776.16.9.1315.
3
Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.白三烯受体拮抗剂和长效β2肾上腺素受体激动剂与吸入性糖皮质激素联合治疗哮喘的耐受性概况:一项综述
J Asthma. 2007 Jul-Aug;44(6):411-22. doi: 10.1080/02770900701247178.
4
Beta-adrenoceptor responses of the airways: for better or worse?气道的β-肾上腺素能受体反应:是福是祸?
Eur J Pharmacol. 2006 Mar 8;533(1-3):15-27. doi: 10.1016/j.ejphar.2005.12.060. Epub 2006 Feb 15.
5
Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma.
J Allergy Clin Immunol. 2000 Sep;106(3):500-6. doi: 10.1067/mai.2000.109425.
6
Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review.作为支气管扩张剂的毒蕈碱拮抗剂 - β - 肾上腺素能激动剂双重药理学分子:专利综述
Expert Opin Ther Pat. 2009 Jan;19(1):1-12. doi: 10.1517/13543770802630331.
7
Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.新型吸入性毒蕈碱拮抗剂阿地溴铵的特性:作用时间长且具有良好的药理学特征。
J Pharmacol Exp Ther. 2009 Nov;331(2):740-51. doi: 10.1124/jpet.109.151639. Epub 2009 Aug 26.
8
Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.吸入皮质类固醇和长效β2-激动剂治疗患者的潜在副作用。
Respir Med. 2009 Apr;103(4):566-73. doi: 10.1016/j.rmed.2008.10.028. Epub 2009 Jan 10.
9
Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.第四部分:β2 肾上腺素能受体的基因变异:长效和短效β2 激动剂与治疗反应
Curr Med Res Opin. 2007 Sep;23 Suppl 3:S29-36. doi: 10.1185/030079907.
10
[Pharmacological therapy of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病的药物治疗]
Ann Ist Super Sanita. 2003;39(4):557-72.

引用本文的文献

1
β(2) -adrenoceptor agonists: current and future direction.β2-肾上腺素受体激动剂:现状与未来方向。
Br J Pharmacol. 2011 May;163(1):4-17. doi: 10.1111/j.1476-5381.2011.01216.x.